Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

55.54 -1.53 (-2.68%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Pharmacy Chains Like CVS Health, Walgreens Boots Alliance Confront Shifting Consumer Habits And Profit Pressures
Walgreens and CVS face declining profits as falling reimbursement rates, rising costs, and competition challenge the retail pharmacy model. Both companies are rethinking strategies, including store... 
Via Benzinga
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Decoding CVS Health's Options Activity: What's the Big Picture?
Via Benzinga
Is CVS Health Stock in Trouble After Reducing Its Guidance for a Third Straight Quarter?
The stock trades at a discount and is near its 52-week low, but is it too risky to invest in CVS Health today? 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
AM Best Revises Issuer Credit Rating Outlooks to Stable for Most of CVS Health Corporation’s Aetna Inc. Subsidiaries
From AM Best
Via Business Wire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
A Glimpse Into The Expert Outlook On CVS Health Through 5 Analysts
Via Benzinga
1 Beaten-Down Stock to Buy and 2 to Avoid
One of these stocks is not like the others. 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Three stocks stand out for investors after they fit the Goldman Sachs analyst recommended criteria of stock picking in today's market environment 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
ROSEN, A LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
What's Going On With CVS Health Stock?
CVS Health shares are trading flat during Friday's session. The company this week reported disappointing Q2 sales and lowered its FY24 adjusted EPS guidance. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast
Via Benzinga
Topics Stocks
Exposures US Equities
Wall Street Poised For Second Day Of Gains While Bank Of Japan Makes Reassurances; Dollar Strengthens Against Yen, Crude Prices Surge: What's Driving Markets Wednesday?
The U.S. 
Via Benzinga
CVS Health (CVS) Q2 2024 Earnings Call Transcript
CVS earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
CVS Stock Earnings: CVS Health Beats EPS, Misses Revenue for Q2 2024
CVS stock results show that CVS Health beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
CVS Health Reports Mixed Q2 Earnings, Lowers 2024 Outlook, Reshuffles Segment Management
CVS Health stock dipped premarket Wednesday after mixed Q2 earnings and lowered annual profit guidance. Sales missed expectations at $91.23B. Adjusted EPS dropped to $1.83, below consensus. Leadership... 
Via Benzinga
Topics Earnings
Exposures Financial
Dow Snaps 3-Session Losing Streak As Nvidia, Meta, And Other Tech Stocks Surge: Greed Index Remains In 'Extreme Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Disney, CVS Health And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to put the worst behind. Volatility continued to drop, as evidenced by... 
Via Benzinga
Topics Stocks
Exposures US Equities
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
3 Unstoppable Dividend Stocks Yielding More Than 4% for Income-Seeking Investors to Buy in August and Hold Forever
The dividend payments you can receive from these high-yield stocks are yours to keep, regardless of a market correction. 
Via The Motley Fool
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.